Cai et al. found that the TRPV6 pathogenic mutation R532Q enhances the TRPV6/PI3K interaction, thereby activating the PI3K/Akt/GSK-3β cascade to further promote breast cancer migration [75]. Here, TRPV6 is linked to breast carcinoma.